Cargando…
A First-in-Human Study To Assess the Safety and Pharmacokinetics of LYS228, a Novel Intravenous Monobactam Antibiotic in Healthy Volunteers
Infections caused by antibiotic-resistant Gram-negative bacteria expressing extended-spectrum β-lactamases and carbapenemases are a growing global problem resulting in increased morbidity and mortality with limited treatment options. LYS228 is a novel intravenous monobactam antibiotic targeting peni...
Autores principales: | Osborn, Megan, Stachulski, Noah, Sun, Haiying, Blais, Johanne, Venishetty, Vinay, Raccuglia, Marc, Kankam, Martin, Colvin, Richard, Segal, Florencia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6591616/ https://www.ncbi.nlm.nih.gov/pubmed/31061156 http://dx.doi.org/10.1128/AAC.02592-18 |
Ejemplares similares
-
Safety and Pharmacokinetics of Intravenous and Oral Fosmanogepix, a First-in-Class Antifungal Agent, in Healthy Volunteers
por: Hodges, Michael R., et al.
Publicado: (2023) -
Pharmacokinetics and Tolerance of the Phage Endolysin-Based Candidate Drug SAL200 after a Single Intravenous Administration among Healthy Volunteers
por: Jun, Soo Youn, et al.
Publicado: (2017) -
Monobactam formation in sulfazecin by a non-ribosomal peptide synthetase thioesterase
por: Oliver, Ryan A., et al.
Publicado: (2017) -
Synthesis of functionalized 2,3-diaminopropionates and their potential for directed monobactam biosynthesis
por: Lichstrahl, Michael S., et al.
Publicado: (2023) -
Preclinical Pharmacokinetics and Safety of Intravenous RTD-1
por: Park, A. Young J., et al.
Publicado: (2022)